솔디펜스
1,500KRWMarket close of 10/21 (Wed)
Up +4.90%+70KRWMarket close of 10/21 (Wed)
- Open
- 1,430
- High
- 1,510
- Low
- 1,391
- Day range
- Day range low 1,391 high 1,510, open 1,430, close 1,500, previous close 1,430
- Volume
- 11×10K shares
- 159.10 million KRW 0.47× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
16%1-year close range 1,127 to 3,505 won, 16% up from the low
16% of the way up from the lowest close in 1 year (252 sessions) · -57.2% from the high
Usual range
Nothing unusual in the 3 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsnot verifiedThe last four quarters are incomplete, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 3 are within the usual range
- Daily move+4.90%usual range
- Trading value0.5×usual range
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue8.7B KRW
- vs. year ago
- —
- vs. prior quarter
- —
- Operating income-781.01 million KRW
- vs. year ago
- —
- vs. prior quarter
- —
- Operating margin-9.0%
- vs. year ago
- —
- vs. prior quarter
- —
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-05-15Same sector · 의료·정밀기기
Up +2.11%· 56 of 101 stocks up, preferred shares excluded · trading value 249.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 나노엔텍 | Close over the last 20 sessions +10.6% | Up +8.13% | 39.0B KRW |
| 케이씨텍 | Close over the last 20 sessions +38.5% | Up +9.89% | 31.4B KRW |
| 디아이 | Close over the last 20 sessions +20.2% | Up +5.63% | 24.2B KRW |
| 티에스이 | Close over the last 20 sessions +9.5% | Up +3.42% | 20.1B KRW |
| 레메디 | Close over the last 20 sessions -0.3% | Up +4.50% | 19.6B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.